Sutro Biopharma, Inc. · NASDAQ:STRO
Srinivas Akkaraju reported a 6.40% stake in Sutro Biopharma, Inc. (Schedule 13G)
Event Feb 11, 2026 · Filed May 15, 2026
Srinivas Akkaraju reported a 6.40% stake in Sutro Biopharma, Inc., 1,062,872 shares, as a passive investor on Feb 11, 2026. Filed May 15, 2026 (Schedule 13G).
- Stake
- 6.40%
- Shares
- 1,062,872
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 5 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Samsara BioCapital, L.P. | 2.50% | 419,095 |
| Samsara BioCapital GP, LLC | 2.50% | 419,095 |
| Samsara Opportunity Fund, L.P. | 3.90% | 643,777 |
| Samsara Opportunity Fund GP, LLC | 3.90% | 643,777 |
| Srinivas Akkaraju | 6.40% | 1,062,872 |
Source
Related
- Sutro Biopharma, Inc.
- Srinivas Akkaraju
- Sutro Biopharma, Inc. shareholders
- Form 4 · Gerber Hans-Peter · Sep 22, 2026
- Schedule 13G/A · Point72 Asset Management, L.P. · Aug 14, 2026
- Schedule 13G/A · Perceptive Advisors LLC · Aug 14, 2026
- Schedule 13G · BlackRock, Inc. · Jul 30, 2026
- Form 4 · Chow Gregory K. · Jun 2, 2026